Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
5.33
-0.17 (-3.09%)
At close: Aug 15, 2025, 12:48 PM

Serina Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
56K 3.15M 500K 3.04M
Cost of Revenue
194K 90K 145K 150K
Gross Profit
-138K 3.06M 355K -110K
Operating Income
-17.05M -3.13M -2.27M -1.63M
Interest Income
n/a n/a 1.76K 10.86K
Pretax Income
-11.14M 5.27M -2.68M -1.26M
Net Income
-11.14M 5.27M -2.68M -1.26M
Selling & General & Admin
9.43M 3.89M 1.29M 6.71M
Research & Development
7.48M 2.39M 893K 1.32M
Other Expenses
194K -90K 4.68M -3.36M
Operating Expenses
17.1M 6.19M 6.86M 4.67M
Interest Expense
526K 558K 15.88K 3.09K
Selling & Marketing Expenses
n/a n/a n/a 5.41M
Cost & Expenses
17.1M 6.28M 2.77M 4.67M
Income Tax Expense
n/a -8K n/a n/a
Shares Outstanding (Basic)
7.36M 8.41M 1.08M 1.08M
Shares Outstanding (Diluted)
7.36M 8.41M 1.08M 1.08M
EPS (Basic)
-1.51 0.63 -2.49 -8.05
EPS (Diluted)
-1.51 0.63 -2.49 -8.05
EBITDA
-10.49M 5.92M -7.05M -7.35M
EBIT
-10.68M 5.83M -7.19M -7.49M
Depreciation & Amortization
194K 90K 132K 131K